reversion advanced ebola virus disease nonhuman primates zmapp 
without approved vaccine treatments ebola outbreak management limited palliative care barrier methods prevent transmission approaches however yet end outbreak ebola prolonged presence west africa show combination monoclonal antibodies zmapp optimized two previous antibody cocktails able rescue % rhesus macaques treatment initiated days post-challenge high fever viraemia abnormalities blood count blood chemistry evident many animals zmapp intervention advanced disease indicated elevated liver enzymes mucosal haemorrhages generalized petechia reversed leading full recovery elisa neutralizing antibody assays indicate zmapp cross-reactive guinean variant ebola zmapp exceeds efficacy therapeutics described far results warrant development cocktail clinical use 
